Pluri Inc. Payments for Repurchase of Initial Public Offering
Pluri Inc. (PLUR) reported Payments for Repurchase of Initial Public Offering of $11.80 thousand for the 1-month period ending 2022-09-21, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2023-11-13
- 2022-09-21: Payments for Repurchase of Initial Public Offering $11.80B; Payments for Repurchase of Initial Public Offering 1 month $11.80K; Payments for Repurchase of Initial Public Offering 1 month as first filed $11.80M.
| Period end | Payments for Repurchase of Initial Public Offering | Payments for Repurchase of Initial Public Offering 1 month | Payments for Repurchase of Initial Public Offering 1 month as first filed |
|---|---|---|---|
| 2022-09-21 | $11.80B 10-Q · filed 2023-11-13 | $11.80K 10-Q · filed 2023-05-09 | $11.80M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |